Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02877394 · ClinicalTrials.gov registry record · Phase 2

Use of a Squatting Assist Device in Patients With Constipation

A Phase 2 study of Constipation, sponsored by Mayo Clinic.

Active
Registry status
Phase 2
Development phase
85
Enrollment target
1
Study location

NCT02877394: Active Phase 2 study of Constipation, sponsored by Mayo Clinic.

NCT02877394 is a Phase 2 study of Constipation that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 85 participants, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02877394, a Phase 2 study of Constipation, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

Constipation is a very common problem. Western style toilets that are nearly universal in the United States require the person to sit on the toilet. However, results from uncontrolled studies suggests that a squatting posture (as prevalent in many foreign countries) may be better at facilitating evacuation compared to a Western style commode. One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. Hence, the investigators propose to evaluate the benefits of a footstool on symptoms and anorectal functions in constipated patients. Hypothesis: the regular squatting assist device (7 inches) but not a sham device (2 inches tall) will improve symptoms of constipation.

Primary Outcome

Subjects completed a bowel diary indicating the number of CSBMs they had each week. Weekly CSBM Frequency = (Number of CSBMs recorded in 7 days/Number of days with bowel entries in subject diary) X 7

Conditions Studied

Interventions

  • DEVICE Squatting Assist Device
  • DEVICE Sham Squatting Assist Device

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2016-09-01
Est. Completion 2026-12
Phase Phase 2
Mayo Clinic

2,844 total trials

What the registry record for NCT02877394 still lists

NCT02877394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (58% lower).

The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 2 interventions - of which Squatting Assist Device is the first listed.

NCT02877394 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02877394 about?

NCT02877394 is a clinical study titled "Use of a Squatting Assist Device in Patients With Constipation". Constipation is a very common problem. Western style toilets that are nearly universal in the United States require the person to sit on the toilet. However, results from uncontrolled studies suggests that a squatting posture (as prevalent in many foreign countries) may be better at facilitating eva...

What is the current status of trial NCT02877394?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 85 participants. The study started on 2016-09-01. Estimated completion is 2026-12.

What conditions does trial NCT02877394 study?

This clinical trial studies the following conditions: Constipation.

What interventions are being tested in trial NCT02877394?

The interventions under investigation include: Squatting Assist Device (DEVICE), Sham Squatting Assist Device (DEVICE).

Who is sponsoring clinical trial NCT02877394?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02877394 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02877394's enrollment target sits among peer trials

85 22nd of 54 higher than 33 of 54 other Constipation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Constipation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02877394, the US trial registry maintained by the National Library of Medicine. NCT02877394 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.